Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Don Walster who wrote (103)	11/6/1998 6:24:00 PM
From: David Israel-Rosen	Respond to of 1386

Dear Don: Hold on to your shares. Pharmos stock is worth something north of $10 a share if sold TODAY. I hope that all Agis will do is enhance shareholder value and I intend to help, as they are highly SOFISTICATED in the know investors good luck david

To: Don Walster who wrote (103)	11/7/1998 10:34:00 AM
From: Omer Shvili	Respond to of 1386

Don, You're jumping to conclusions way too fast. David is adding very wild analysis to his words. 5.2% is far from being enough to control a company, that's obvious to everyone. When David says he's afraid, PARS will be bought at a low price, he means $4 - $5 per share, not lower than that. There is a very slim chance of that happening (big pharma like partnership deals and not to outright buy a company). Nothing has changed, and you shouldn't do anything differently just because of this piece of news. Omer